Document Detail


Occurrence of neurolepric malignant syndrome on trihexphenidyl discontinuation.
MedLine Citation:
PMID:  21584140     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
The neuroleptic malignant syndrome (NMS) commonly occurs on treatment with neuroleptics, it is also reported in patients who suddenly stop drugs like levodopa, amitriptyline and imipramine. We report a case of NMS, which occurred in a patient on lithium, haloperidol and trihexyphenidyl (THP) after sudden discontinuation of THP. The cholinergic system, through its effect on the dopaminergic system, may play a role in the genesis of NMS. Alternatively, anticholinergic withdrawal may produce extrapyramidal symptoms (EPS), and the consequent alteration in food and fluid intake may produce electrolyte imbalance which increases the risk for NMS.
Authors:
J P Alexander; R M Thomas; A Das
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of psychiatry     Volume:  38     ISSN:  0019-5545     ISO Abbreviation:  Indian J Psychiatry     Publication Date:  1996 Oct 
Date Detail:
Created Date:  2011-05-17     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  0013255     Medline TA:  Indian J Psychiatry     Country:  India    
Other Details:
Languages:  eng     Pagination:  250-3     Citation Subset:  -    
Affiliation:
P. John Alexander, M.D., Associate Professor, Department of Psychiatry, Kasturba Medical College, Manipal - 576 119.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparative study of side-effects of lithium, carbamazepine and haloperidol in acute mania.
Next Document:  Delusions of pregnancy - a report of four cases.